Diamond Sponsors
Platinum Sponsors
Gold Sponsors
Silver Sponsors
About Thoracic Oncology Frontiers
An international multidisciplinary event bridging translational research and clinical medicine, this meeting will convene global leaders across thoracic oncology to improve MDT decision making and accelerate translation of trial evidence into real-world practice.
This two day international conference will bring together leaders across the thoracic oncology pathway to explore advances in:
- Multimodal treatment strategies
- Neoadjuvant & perioperative therapy
- Radiotherapy integration
- Surgical innovation
- Molecular selection
- Imaging & response assessment
- Oligometastatic disease
The meeting aims to improve MDT decision-making, explore sequencing of therapies and translate trial evidence into real-world pathways.
CPD points pending.
Who is the Thoracic Oncology Frontiers for?
This conference is designed for professionals involved across the thoracic oncology pathway, including medical oncologists, clinical and radiation oncologists, thoracic surgeons, respiratory physicians, radiologists, pathologists, research leaders, nursing and allied health professionals, and guideline contributors.
Steering Committee Chairs
Dr Sean Dulloo (Chair)
Dr Sean Dulloo is a Consultant Medical Oncologist and Honorary Associate Professor at University Hospitals of Leicester NHS Trust and the University of Leicester. He is Head of Service for Oncology and Clinical Lead for Thoracic Oncology, with specialist expertise in lung cancer and pleural mesothelioma focusing on novel therapeutics.
Dr Dulloo completed his oncology training in Leicester and earned an MD focused on epithelial–mesenchymal transition in mesothelioma. He serves as Chief and Principal Investigator for numerous international clinical trials, including early-phase studies, and has presented at major international conferences. His research has been widely published in leading peer-reviewed journals, including Nature.
Sridhar Rathinam FRCSEd(CSiG), FRCSEd(CTh), FFSTEd
Mr Sridhar Rathinam is a Consultant Thoracic Surgeon and Head of Service at University Hospitals of Leicester, specialising in parenchyma-preserving lung cancer surgery, minimally invasive thoracic surgery, chest wall surgery and emphysema surgery. His research interests include lung cancer biomarkers, perioperative care and surgical innovation, and he is Principal Investigator for several NIHR clinical trials. An internationally recognised surgical educator, he has held senior leadership roles with the Society for Cardiothoracic Surgery and the Royal College of Surgeons of Edinburgh. Mr Rathinam has published extensively and is committed to advancing thoracic surgery through research, education and simulation-based training.
Amrita Bajaj
Dr Amrita Bajaj is a Consultant Radiologist at University Hospitals of Leicester, specialising in thoracic oncology, molecular imaging, and translational cancer research. Her work integrates advanced imaging, PET-CT, image-guided biopsy, quantitative imaging biomarkers, and artificial intelligence (AI) to improve tumour characterisation and treatment response assessment. Her research focuses on innovative, personalised approaches in lung cancer and mesothelioma, including imaging-based evaluation of tumour biology, and AI-driven solutions to advance precision oncology and clinical translation.
Keynote Speakers for 2027
Dr Suresh Ramalingam
Board certified in medical oncology, Suresh S. Ramalingam, MD, FACP, FASCO, is nationally recognized as an investigator and a physician in the area of small cell and non-small cell lung cancer.
Dr. Ramalingam serves as executive director of Winship Cancer Institute of Emory University and associate vice president for cancer of Woodruff Health Sciences Center. He is past- president of the Georgia Society of Oncology and a member of the board of Georgia CORE. He is a Fellow of the American Society of Clinical Oncology and a Georgia Cancer Coalition Distinguished Cancer Scholar.
Dr. Ramalingam has been named to the MilliPub Club, which recognizes current Emory University School of Medicine faculty who have published one or more individual papers throughout their careers that have garnered more than 1,000 citations.
Dr. Ramalingam was named to the 2025 TIME100 Health, a recognition by TIME magazine which honors the 100 most influential individuals in health in the world.
Professor Suresh Senan
Professor Suresh Senan is a radiation oncologist at the Amsterdam University Medical Centers, The Netherlands. After training in general internal medicine at the National University Hospital, Singapore, he trained in clinical oncology at the Beatson Oncology Center, Glasgow. His subsequent career has been based in the Netherlands since 1994, where his recent research has focused on the use of immune checkpoint inhibitors in lung malignancies, exploring new radiotherapy techniques and in comparative effectiveness research. He is a longstanding faculty member for thoracic malignancies at the European Society of Medical Oncology and teaching faculty for the Image-guided SBRT course of the European Society for Radiation Oncology. Professor Senan is also an active member of the International Association for the Study of Lung Cancer and ASCO.
Professor Isabelle Opitz
Professor Isabelle Opitz is the Director of the Department of Thoracic Surgery, Chair of the Lung Cancer Center, and a Board Member of the Robotic and Transplant Center at University Hospital Zurich, Switzerland and Professor Ordinaria of Thoracic Surgery at the University of Zurich. Her surgical expertise includes the treatment of thoracic cancers, in particular robotic surgery, lung transplantation and pulmonary endarterectomy. Her work has generated > 290 peer-reviewed articles and culminated in multiple principal investigator grants from the Swiss National Science Foundation and other national and international grants. In 2023, she was honored with the Tudor Edwards Lecture Award from SCTS, and in 2022, she received the Robert J. Ginsberg Lectureship Award for Surgery from IASLC. She is a Past President and Past Treasurer of the ESTS, where she continues to contribute as a member of the Robotic Working Group, organizing the ESTS Robotic Academy. She also chairs the Thoracic European Surgical Trials (TEST) Clinical Trials Platform. Additionally, she serves as Board Member of IASLC and is Chair of the Meso Committee of the 10th TNM edition. She is further Board Member of iMig and the Swiss Association of Thoracic Surgeons (SGT). She was a member of the research council of the Swiss National Science Foundation, the central funding body for basic research in Switzerland, commissioned by the federal government, for 5 years. She was International Director of AATS (2022–2025) and remains active on their Thoracic Education Committee and the Thoracic Clinical Practice Standards Committee.
Steering Committee Members
Dean Fennell
Sridhar Thiagarajan
Giuseppe Banna
Cathy Richards
Apostolos Nakas
Maninder Kalkat
Indrajeet Das
Liz Darlison
Rajini Sudhir
Sharon Savory
Kevin Franks
Jonathan Bennett
International Scientific Committee/ Faculty
Prof. Jarushka Naidoo
Professor Jarushka Naidoo is Professor of Medical Oncology at Beaumont RCSI Cancer Centre, Dublin, and Adjunct Professor of Oncology at Johns Hopkins University. An internationally recognised thoracic oncologist, her research focuses on lung cancer immunotherapy and immune-related toxicities. She has led numerous investigator-initiated clinical trials and published over 100 peer-reviewed papers in this field. Professor Naidoo chairs the Lung Cancer Disease-Specific Subgroup of Cancer Trials Ireland and founded the Irish Lung Cancer Alliance. Her contributions to clinical research have earned multiple international awards, including the Irish Cancer Society Clinician Research Leader Award in 2021.
Prof. Paul Van Schil
Professor Paul Van Schil is Professor Emeritus of Thoracic and Vascular Surgery at the University of Antwerp and Consultant Thoracic Surgeon at Antwerp University Hospital, Belgium. An internationally recognised leader in thoracic surgery, his clinical and research interests include lung cancer staging, multimodality therapy, thymoma and mesothelioma. He served as President of the European Association for Cardio-Thoracic Surgery (2013–2014) and was President of the International Association for the Study of Lung Cancer (IASLC) from 2023–2025. Professor Van Schil currently serves as Past President of IASLC and Associate Editor of the Journal of Thoracic Oncology.
Prof. Arnaud Scherpeel
Professor Arnaud Scherpereel is Professor of Respiratory Medicine at Lille University Hospital, France, where he leads the Heart, Lung and Vessels Division and co-directs the ONCOLille Cancer Research Centre. An internationally recognised expert in thoracic oncology, pleural disease and mesothelioma, he coordinates the French National Mesothelioma Network (NETMESO). His research focuses on tumour immunology, innovative therapies and early cancer diagnosis. Professor Scherpereel has authored over 225 peer-reviewed publications, led numerous international clinical trials, received the 2019 European Respiratory Society Gold Medal in Lung Cancer, and served as President of the International Mesothelioma Interest Group (2021–2025).
About The Organiser
The Institute of Thoracic Cancer, Leicester brings together specialist expertise in Oncology, Thoracic Surgery, Respiratory Medicine, Pathology and Radiology to provide coordinated multidisciplinary care, advance thoracic cancer research and improve outcomes for patients.
Event Venue
Leicester Marriott
Address: Grove Park, Smith Way, Enderby, Leicester, LE19 1SW, UK
Accommodation: Conference delegates can book their own overnight accommodation directly with the Leicester Marriott hotel at a special conference rate of £121.00 which includes Breakfast & Car Parking (subject to availability).
